ONCOLOGY INFORMATION SYSTEMS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global Oncology Information Systems Market Size and Share Analysis – Growth Trends and Forecasts (2025-2032)

Global Oncology Information Systems Market is estimated to be valued at USD 9.52 Bn in 2025 and is expected to reach USD 16.11 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Key Takeaways

• Based on Application, The Patient Information System Segment dominates the Oncology Information Systems market with a 40.5% market share. This is due to its central role in managing comprehensive cancer patient data across diagnosis, treatment, and follow-up.
• North America is expected to be the largest market for the global oncology information systems market during the forecast period, accounting for over 39.3% of the market share in 2025. The growth of the market in North America is attributed to favorable government policies, high adoption of EHRs, advanced healthcare IT infrastructure, and high cancer prevalence.
• Europe is expected to be the second-largest market for the global oncology information systems market, accounting for over 28.2% of the market share in 2025. The growth of the market in is attributed to developed healthcare IT infrastructure, increasing cancer cases, and investments in oncology informatics.
• Asia Pacific is expected to be the fastest-growing market for the global oncology information systems market, with a CAGR of over 22.5% during the forecast period. The growth of the market in Asia Pacific is attributed to the improving healthcare infrastructure, rising disposable incomes, and increasing awareness about oncology information systems.

Market Overview

The Oncology Information Systems (OIS) market is driven by the increase in the global cancer burden, increasing demand for efficient care coordination, and need for integrated data management across the continuum of cancer care. With the number of cancer cases still increasing, healthcare providers require electronic platforms to observe patient data in real time, orchestrate personalized treatment, and track outcomes. OIS platforms allow clinicians to rationalize complex oncology workflows, improve clinical decision-making, and minimize treatment errors.

In 2025, MediTrack Health launched its Oncology Intelligence Suite, a cloud-based OIS offering that forecast treatment outcomes, identify clinical hazards, and enable automated cancer staging on structured and unstructured patient data. The solution employs natural language processing and machine learning to enable oncologists to make timely, fact-based decisions while having full continuity with electronic health records and national cancer registries.

Current Events and Its Impact on Oncology Information Systems Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pipeline Analysis

The oncology information systems (OIS) market pipeline is accelerating with advancements across cloud computing, AI-fueled analytics, interoperability, and decentralized care solutions. Mid-stage developments feature centrally cloud-based OIS platforms that provide scalable, secure patient data access and treatment planning. RaySearch Laboratories has just introduced Ray Intelligence, a cloud-native analytics platform deeply integrated with RayCare, for boosting scheduling, DICOM management, and treatment reporting.

AI and machine-learning technologies are being implemented in pipeline systems to aid clinical decision-making. Current pilots include LLM‑based mCODE integration and AI‑powered decision support for the treatment of conditions such as skin cancer, enhancing interoperability and diagnostic accuracy by organizing unstructured patient data.

Interoperability is a focus area of ongoing development. Vendors are creating solutions that integrate OIS with EHRs, RIS, LIS, and genomic platforms. Siemens‑Varian and Cigna's Ever north‑Varian collaborations are themselves promoting FHIR standardization for data exchange. Tele oncology and remote monitoring pipelines are also on the rise. They enable virtual consultation and decentralized clinical trials, taking cancer care outside traditional confines.

Geographically, Asia‑Pacific has significant growth concentration with increased cancer incidence and investment in healthcare IT, led by countries such as India and China, where pipelines for fast build-out of digital infrastructure are envisioned. These technologies are anticipated to reach pilot or commercial phases by 2026–2027, facilitating more effective, tailored, and open oncology processes throughout the world.

Patent Landscape

The patent environment in the Oncology Information Systems (OIS) market is transforming with the evolution of cancer care, digital health, and precision medicine. Initial patents in this arena largely centered on central system architecture—treatment planning integration, automation of radiotherapy workflow, and cancer staging protocol—setting the stage for contemporary OIS platforms. Patents such as US 9,764,162 and US 2008/0103831 A1 are representative of early systems intended to orchestrate oncology workflows, patient data, and clinical decision-making.

There has been a greater emphasis in recent years on analytics powered by AI, cloud technology, and data interoperability. A large number of more recent patent filings are focused on artificial intelligence for clinical decision support, especially treatment suggestion, tumor profiling, and image analysis. While most AI patents come from related fields such as digital pathology and medical imaging, their methodologies are increasingly being incorporated into OIS platforms for improving diagnostic accuracy and treatment planning.

In addition, cloud-based OIS platforms are coming under patent scrutiny as suppliers seek scalable, secure, and remote-accessible platforms. Interoperability is another significant patent trend, particularly with the implementation of data standards such as HL7 FHIR and mCODE (Minimal Common Oncology Data Elements), allowing for frictionless data exchange within healthcare ecosystems.

Geographically, the United States leads the way in OIS-related patent applications, followed by Europe and China, indicating heavy investment in oncology technology and digital infrastructure. As cancer treatment becomes more data-intensive and personalized, the patent landscape will increasingly become more complex, extending to real-time analytics, genomic data integration, and remote oncology workflows—intellectual property becomes a strategic asset in this competitive, technology-savvy market.

Global Oncology Information Systems Market Drivers

• Rising prevalence of cancer globally

The rising prevalence of cancer across the globe is a major factor driving the growth of the oncology information systems market. With increasing cancer incidence rates, the patient pool undergoing diagnosis and treatment for various cancers has expanded significantly. This has created an urgent need for robust oncology informatics platforms that can efficiently capture and manage information throughout the care continuum to improve outcomes.

Oncology information systems aid in tracking real-time patient data, care coordination, treatment planning and clinical research in cancer care. Their adoption is rising rapidly in line with the growing cancer burden worldwide.

In May 2025, NHS England began rolling out its “Cancer 360” digital data integration tool to accelerate cancer diagnosis and treatment. Piloted at the Royal United Hospital in Bath and Chelsea & Westminster Hospital, Cancer 360 centralizes fragmented patient information replacing spreadsheets, emails, and paper records—to support prompt clinical decision making and ensure clinicians meet the 28‑day cancer diagnosis target.

• Need for integrated healthcare IT platforms

Healthcare providers are increasingly looking to integrate their disparate healthcare IT systems and medical devices onto unified platforms to enable seamless workflows and care coordination. Oncology information systems serve as centralized hubs that can consolidate key patient data from diverse systems including EHRs, RIS, PACS, monitoring devices, etc.

By linking clinical, operational, administrative, and financial data, these systems provide a 360-degree view of patient information to optimize care delivery across multidisciplinary teams involved in cancer treatment. Their ability to unify data is driving adoption across cancer centers and hospitals.

• Favorable government policies

Government regulations and incentive programs to promote the adoption of advanced healthcare IT solutions are catalyzing the oncology information systems market growth. For instance, laws mandating or encouraging EHR implementation in many countries are providing impetus to these systems as they can integrate tightly with existing EHRs. Favorable reimbursement policies for cancer therapies supported by robust informatics are also driving the deployment of these solutions across clinical settings.

• Expanding personalized medicine

The emergence of precision medicine and molecular profiling is creating demand for advanced oncology informatics platforms. As cancer treatment becomes more targeted with the use of biomarkers and genomic testing, oncology information systems are required to collect, analyze and exchange high volumes of patient molecular data to enable personalized therapy decisions. Their workflow automation and analytics capabilities are invaluable in the expanding precision oncology space.

Global Oncology Information Systems Market Opportunities

• Cloud-based solutions

The availability of cloud-based oncology information system solutions has opened new growth opportunities in the market. Cloud-based systems offer various advantages like lower upfront costs, scalability, easier upgrades, and 24/7 accessibility to data. As healthcare providers of all sizes look to leverage the cloud’s economies of scale and agility, the adoption of cloud-based oncology informatics solutions is expected to rise. This provides significant growth opportunities for vendors in the space.

• Artificial intelligence

Incorporating AI and machine learning capabilities within oncology information systems unlocks new opportunities for data-driven insights and clinical efficiency. AI can automate mundane tasks, enable predictive analytics, personalized treatment recommendations and streamline reporting. As AI adoption gains momentum in healthcare, integration with oncology informatics platforms will become imperative. This creates substantial opportunities for advanced AI-powered solutions.

• Improving IT infrastructure in emerging markets

Emerging countries are currently investing heavily in health IT infrastructure development including implementation of EHR systems, data analytics tools, and care coordination platforms. This improving IT landscape coupled with rising cancer burden in developing economies is creating massive opportunities for oncology information system vendors. Local partnerships and tailored solutions focused on emerging markets will be key growth strategies.

• mHealth integration

Seamless integration with mHealth apps and wearable devices provides significant growth opportunities for oncology information systems. Patients can self-report symptoms, medication intake, vital parameters, etc. through mHealth solutions integrated with these systems, enabling remote patient monitoring. As telehealth gains momentum, integration opportunities will expand driving adoption of interoperable systems.

Global Oncology Information Systems Market Trends

• Company Acquisitions

Market players operating in the market are focused on strategies, such as acquisitions, and this is expected to boost the growth of the market over the forecast period. For instance, on September 26, 2023, Varian Medical Systems, Inc., a healthcare technology company providing oncology information systems among other products, announced that it has acquired Aspekt Solutions, a healthcare company. Varian Medical System's Advanced Oncology Solutions (AOS) products will be expanded as a result of the acquisition of Aspekt Solutions.

• Patient engagement solutions

To improve care coordination and patient outcomes, oncology information systems are converging with patient engagement platforms, providing customized education, symptom tracking, remote access to records, self-scheduling, and others. Enabling patients’ active participation in their care through engagement solutions integrated with oncology informatics will be crucial.

• Interoperability focus

A major technology trend is the increased focus on interoperability and standards-based data sharing between oncology information systems and other hospital IT systems. Seamless bidirectional data exchange between oncology informatics, diagnostic systems, medical devices, research databases, registries, and EHRs are critical for coordinated care. Advancing interoperability is a key trend.

• Workflow automation

Oncology information systems are leveraging emerging technologies like AI, blockchain, and IoT (Internet of Things) to enable greater workflow automation - from clinical trial management to radiation dose tracking. By reducing administrative overheads and manual errors, workflow automation delivers productivity gains for healthcare organizations. It is a major technology trend in this space.

Global Oncology Information Systems Market Restraints

• Data privacy and security concerns

Patient data privacy and security concerns associated with digital oncology records remain a major restraint to the adoption of these systems. As these platforms capture and store highly sensitive patient information, risks related to cyberattacks, data breaches, and unauthorized access persist.

Additionally, interoperability challenges between different healthcare IT systems can further complicate secure data exchange. The lack of skilled personnel and inadequate IT security infrastructure makes it difficult for many healthcare providers to fully embrace oncology informatics solutions.

• High upfront costs

The significant upfront costs of oncology information systems—including expenses related to software, hardware, implementation, training, and ongoing maintenance—make adoption prohibitive for smaller clinics and healthcare centers. Many of these providers are hesitant to invest in costly digital platforms and often continue relying on traditional paper-based records.

Furthermore, interoperability challenges in oncology information systems among legacy systems and new digital platforms add to the complexity and cost of deployment. Combined with tight budgets and limited access to funding, these factors continue to hinder widespread adoption across the oncology care landscape.

Segmental Insights

To learn more about this report, Download Free Sample

Oncology Information Systems Market Insights, By Application

The patient information system dominates the Oncology Information Systems market with a 40.5% share due to its central role in managing comprehensive cancer patient data across diagnosis, treatment, and follow-up. It enables seamless integration of medical history, lab results, imaging, and treatment plans, ensuring coordinated care.

With rising cancer cases, healthcare providers need robust systems to track complex, multi-phase oncology treatments. These systems also support regulatory compliance and clinical decision-making. Their wide applicability across hospitals and cancer centers drives higher adoption compared to niche applications.

Global Oncology Information Systems Market – Regional Insights

To learn more about this report, Download Free Sample

• North America is expected to be the largest market for the global oncology information systems market during the forecast period, accounting for over 39.30% of the market share in 2025. The growth of the market in North America is attributed to favorable government policies, high adoption of EHRs, advanced healthcare IT infrastructure, and high cancer prevalence.
• Europe is expected to be the second-largest market for the global oncology information systems market, accounting for over 28.2% of the market share in 2025. The growth of the market in is attributed to developed healthcare IT infrastructure, increasing cancer cases, and investments in oncology informatics.
• Asia Pacific is expected to be the fastest-growing market for the global oncology information systems market, with a CAGR of over 22.5% during the forecast period. The growth of the market in Asia Pacific is attributed to the improving healthcare infrastructure, rising disposable incomes, and increasing awareness about oncology information systems.

Oncology Information Systems Market Dominating Countries

United States Oncology Information Systems Market Analysis and Trend

The U.S. dominates the global OIS market with its sophisticated healthcare IT infrastructure, elevated cancer incidence, and robust investment in precision medicine. Key players such as Varian, Elekta, and RaySearch have a strong presence, and adoption of EHRs and cloud-based oncology platforms at large facilitates the growth of OIS solutions complemented with AI and real-time analytics.

Germany Oncology Information Systems Market Analysis and Trend

Germany is one of Europe's most important OIS markets, with its extensive cancer treatment programs and hospital digitization initiatives under the Hospital Future Act. German hospitals are increasingly implementing interoperable systems for radiation therapy and oncology data management, driving demand for integrated OIS platforms.

Japan Oncology Information Systems Market Analysis and Trend

Japan's aging population and high incidence of cancer are the factors driving increasing demand for oncology IT systems. The emphasis of Japan on minimally invasive treatments and workflow integration of radiology, pathology, and oncology workflows makes OIS systems an essential element in the handling of intricate cancer treatment.

India Oncology Information Systems Market Analysis and Trend

India is a growing market for OIS, driven by increasing cancer incidence, fast growth in digital healthcare, and government programs such as Ayushman Bharat. Urban cancer facilities are starting to embrace cloud-based oncology platforms for enhanced patient tracking, although widespread adoption is at an early stage.

Market Report Scope

Recent Developments

• In 2025, Fujitsu introduced an advanced oncology software system in Japan focusing on compliance with national data regulations and user-friendly interfaces for cancer treatment planning and monitoring.
• In 2025, Varian introduced a next-generation Oncology Information System that integrates AI-based treatment planning and predictive analytics. The system enhances workflow automation and clinical decision-making across radiotherapy and medical oncology. It reflects the industry's shift toward personalized, data-driven cancer care platforms.

Analyst’s Views

• The oncology information systems market is set to witness substantial growth in the coming years. This growth is primarily driven by the increasing prevalence of cancer globally and the growing need for efficient and effective systems to manage and streamline oncology treatment. The integration of advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) in oncology information systems is revolutionizing cancer care, making treatment more personalized and precise.
• These advancements are expected to further propel the market growth. However, the market also faces challenges such as high costs associated with the implementation of these systems and a lack of skilled professionals to operate them. Additionally, issues related to privacy and data security in oncology information systems could also hinder market growth.
• Despite these challenges, the trend of company acquisitions is providing a significant boost to the market. Large healthcare IT companies are acquiring smaller firms to enhance their product portfolio and expand their market presence. This trend is expected to continue, contributing to the market's expansion. In conclusion, the Oncology Information Systems Market holds promising potential, with technological advancements and strategic acquisitions paving the way for a more efficient and effective cancer care landscape.

Market Segmentation

• By Type
  • Patient Information Systems Patient Information Systems
  • Treatment Planning Systems
  • Task & Workflow Management Systems
  • Clinical Trial Management Systems
  • Others
• By Application
  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology
• By End User
  • Oncology Centers
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Physician Offices
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Company Profiles
  • Cerner Corporation Cerner Corporation
  • Elekta
  • Accuray
  • RaySearch Laboratories
  • Flatiron Health
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Epic Systems Corporation
  • CureMD
  • Varian Medical Systems, Inc.
  • Brainlab
  • Siemens Healthcare Private Limited
  • Oracle
  • Karkinos Healthcare Private Limited

Sources

Primary Research Interviews

• Oncology Information System Vendors and Solution Providers
• Healthcare IT Directors and CIOs at Cancer Centers
• Oncology Practice Administrators and Managers
• Medical Oncologists and Radiation Oncologists
• Others

Databases

• Healthcare Information and Management Systems Society (HIMSS) Database
• Global Health Observatory (GHO) Database
• Cancer Statistics Database (GLOBOCAN)
• National Cancer Institute (NCI) Database
• Others

Magazines

• Healthcare IT News
• Modern Healthcare Technology
• Cancer Network Magazine
• Oncology Business Review
• Others

Journals

• Journal of Medical Internet Research (JMIR)
• Journal of Clinical Oncology
• International Journal of Medical Informatics
• Others

Newspapers

• Healthcare Finance News
• Fierce Healthcare
• Modern Healthcare Daily
• Health Data Management News
• Others

Associations

• American Society of Clinical Oncology (ASCO)
• Healthcare Information and Management Systems Society (HIMSS)
• American Health Information Management Association (AHIMA)
• International Association of Healthcare Central Service Materiel Management (IAHCSMM)
• Others

Public Domain Sources

• World Health Organization (WHO) Publications
• U.S. Food and Drug Administration (FDA) Guidelines
• Centers for Medicare & Medicaid Services (CMS) Reports
• National Cancer Institute (NCI) Public Resources
• Others

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years

*Definition: Oncology information systems are specialized healthcare IT solutions designed specifically for oncology departments, practices, and research centers. They capture, store, and manage key clinical, administrative, and financial and research data related to cancer patients across the care continuum. Oncology information systems integrate with EHRs, medical imaging systems, and revenue cycle management platforms to optimize workflows. They aid in treatment planning, clinical documentation, care coordination, outcomes analysis, and cancer research. With rising cancer prevalence and emphasis on value based patient centric care, the adoption of oncology information systems is increasing globally.